Dr. Lowy is the Principal Deputy Director of the National Cancer Institute (NCI), National Institutes of Health (NIH), and Chief of the Laboratory of Cellular Oncology in the Center for Cancer Research at NCI. He received his medical degree from New York University School of Medicine and trained in internal medicine at Stanford University and dermatology at Yale. Dr. Lowy’s research includes the biology of papillomaviruses and the regulation of normal and neoplastic growth. The papillomavirus research is carried out in close collaboration with Dr. John Schiller, and they were involved in the initial development, characterization, and clinical testing of the preventive virus-like particle-based HPV vaccines that are now used in the three FDA-approved HPV vaccines. Dr. Lowy’s growth regulation research is now focused primarily on the DLC family of tumor suppressor genes and their mechanism of action. In response to the COVID-19 epidemic, he has led the SARS-CoV-2 serology research effort at NCI. Dr. Lowy is a member of the National Academy of Sciences (NAS) and of the Institute of Medicine of the NAS. For their HPV vaccine research, he and Dr. Schiller have received numerous honors, including the 2007 Federal Employee of the year Service to America Medal from the Partnership for Public Service, the 2011 Albert B. Sabin Gold Medal Award, the 2012 National Medal of Technology & Innovation (awarded in 2014), and the 2017 Lasker-DeBakey Clinical Medical Research Award.